Dr. Vinay Prasad will again head the FDA’s Center for Biologics Evaluation and Research, which oversees vaccines and complex treatments for serious diseases, the U.S. Department of Health and Human ...

Today, we discuss lots of government maneuvering that impacts biopharma — starting, of course, with the FDA reinstating Vinay ...

FDA reinstates Vinay Prasad to lead CBER as gene therapy safety concerns spotlight regulatory challenges in biotech manufacturing.

Good morning. A lot happened at federal health agencies this weekend. Scroll down for everything we know about the shooting at CDC headquarters and the sudden return of Vinay Prasad to the FDA. A lot ...